Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Medical University of Vienna

Status: Completed

Conditions: Aortic Valve Disease

Treatments: Device: Aortic Valve Replacement

Study type: Observational

Funder types: Other

Identifiers

NCT05912660

AUTHEARTVISIT - TAVI

Details and patient eligibility

About

The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.

Enrollment: 18,882 patients

Sex: All

Ages: 65 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• isolated aortic valve replacement in Austria (surgically implanted bioprostheses or TAVI)

Exclusion criteria

• below 65 years of age
• coronary revascularization within 4 months before the index procedure
• concomitant heart surgery

Trial design

18,882 participants in 2 patient groups

Aortic valve replacement with surgically implanted bioprostheses

Treatment:

Device: Aortic Valve Replacement

Aortic valve replacement with TAVI

Treatment:

Device: Aortic Valve Replacement